Cargando…
Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods
High-throughput proteomic profiling using antibody or aptamer-based affinity reagents is used increasingly in human studies. However, direct analyses to address the relative strengths and weaknesses of these platforms are lacking. We assessed findings from the SomaScan1.3K (N = 1301 reagents), the S...
Autores principales: | Katz, Daniel H., Robbins, Jeremy M., Deng, Shuliang, Tahir, Usman A., Bick, Alexander G., Pampana, Akhil, Yu, Zhi, Ngo, Debby, Benson, Mark D., Chen, Zsu-Zsu, Cruz, Daniel E., Shen, Dongxiao, Gao, Yan, Bouchard, Claude, Sarzynski, Mark A., Correa, Adolfo, Natarajan, Pradeep, Wilson, James G., Gerszten, Robert E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390994/ https://www.ncbi.nlm.nih.gov/pubmed/35984888 http://dx.doi.org/10.1126/sciadv.abm5164 |
Ejemplares similares
-
Whole Genome Association Study of the Plasma Metabolome Identifies Metabolites Linked to Cardiometabolic Disease in Black Individuals
por: Tahir, Usman A., et al.
Publicado: (2022) -
A parametric bootstrap approach for computing confidence intervals for genetic correlations with application to genetically-determined protein-protein networks
por: Tsai, Yi-Ting, et al.
Publicado: (2023) -
Nontargeted and Targeted Metabolomic Profiling Reveals Novel Metabolite Biomarkers of Incident Diabetes in African Americans
por: Chen, Zsu-Zsu, et al.
Publicado: (2022) -
CYP4F2 is a human-specific determinant of circulating N-acyl amino acid levels
por: Tanzo, Julia T., et al.
Publicado: (2023) -
Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk
por: Ngo, Debby, et al.
Publicado: (2021)